Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia may indicate higher risk for certain diseases and mental health issues.

Topical cetirizine may help increase hair count in androgenetic alopecia.

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.

A new treatment using probiotic microneedles shows promise for promoting hair growth and reducing inflammation in androgenetic alopecia.

A new diagnostic model can help better diagnose and understand Alopecia Areata.

Androgenetic alopecia, or hair loss, is caused by a mix of genetics, hormones, and environment, where testosterone affects hair growth and causes hair to become smaller and grow for a shorter time.

GALT5 and GALT2 are important for plant growth and development because they help with protein glycosylation.

PRP treatment may promote hair growth and improve hair density in women with AGA, but more research is needed.

A 90-year-old man was diagnosed with heart failure due to wild-type transthyretin cardiac amyloidosis.

The treatment showed promising results in improving advanced-stage hair loss.

There are potential treatments for pattern baldness, but more research is needed to confirm their effectiveness.

Testosterone therapy in transgender men can lead to hair loss, with the risk increasing over time and influenced by family history.

Gut bacteria pathways may help treat hair loss in obese people.

Androgenetic alopecia causes hair loss, impacting self-esteem and confidence.

Hair loss in young men linked to higher risk of insulin resistance and metabolic issues.

CAG repeat numbers in the AR gene likely don't affect hair loss in Korean men.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Androgenetic alopecia, or hair loss, is caused by genetic factors and hormones, with different mechanisms in men and women, and can be linked to insulin resistance and polycystic ovary syndrome.

PRP therapy can effectively improve hair growth in young men with early hair loss.

Early hair loss may indicate future prostate issues.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

Androgenetic alopecia in men is genetic and linked to health issues like obesity and heart disease, with treatments including minoxidil, finasteride, and hair transplants.

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.

Scalp dermatoscopy helps diagnose and monitor hair loss severity.

Genetic profiling can improve androgenetic alopecia treatment by predicting drug response and minimizing side effects.

PRP therapy effectively improves hair growth in young men with early-to-moderate hair loss.

Mutations in the Vitamin D receptor gene can cause hair loss similar to mutations in the Hairless gene.

Male pattern baldness is an unintended side effect of the body's use of androgens for muscle growth, especially in those genetically prone to it.

Higher substance P levels may cause discomfort in hair loss patients.

The Trichoscope is a valuable tool for diagnosing and monitoring hair loss conditions.